Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma

Published:2016-03-14 Issue:7 Volume:63 Page:1163-1167
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Riggle Kevin M.¹²,Turnham Rigney³⁴,Scott John D.³⁴,Yeung Raymond S.¹⁵,Riehle Kimberly J.¹²⁵⁶

Affiliation:

1. Department of Surgery University of Washington Seattle Washington

2. Division of General and Thoracic Surgery Seattle Children's Hospital Seattle Washington

3. Howard Hughes Medical Institute University of Washington Seattle Washington

4. Department of Pharmacology University of Washington Seattle Washington

5. Northwest Liver Research Program University of Washington Seattle Washington

6. Department of Pathology University of Washington Seattle Washington

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.25970

Reference50 articles.

1. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

2. Differential diagnosis of tumors and tumor‐like lesions of liver in infancy and childhood;Edmonson HA;AMA J Dis Child,1956

3. A review of 218 pediatric cases of hepatocellular carcinoma

4. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10

5. Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival and remarkably durable treatment response in a case of inoperable fibrolamellar carcinoma of the liver — a comprehensive analysis of an 8-year chemotherapeutic journey;Oncology in Clinical Practice;2024-05-24

2. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma;PLOS Genetics;2024-03-21

3. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma;Cell Reports Medicine;2024-03

4. Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade;Scientific Reports;2024-03-01

5. A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma;Oncology Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3